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Abstract 
Osteoarthritis (OA) is a chronic, disabling disease involving articular joints and is characterized             
by cartilage destruction. Pathological changes associated with osteoarthritis have been          
attributed to the activation of MAP kinase (MAPK) pathways by reactive oxygen species (ROS)              
in response to catabolic stimuli. Additionally, cartilage cells, also known as chondrocytes,            
produce nitric oxide (NO), a ROS. NO has been shown to readily interact with superoxide to                
form peroxynitrite, which in turn, is thought to mediate cartilage damage. Additionally, NO is              
thought to promote signals that increase matrix metalloproteinase (MMP) production, which is            
implicated in the breakdown of the extracellular matrix of cartilage. The purpose of this study               
was to observe how ROS regulate cellular mechanisms of inflammation and cartilage            
degradation in osteoarthritis. Chondrocytes isolated from articular cartilage were treated with           
endotoxin-free recombinant human fibronectin fragment (Fnf) (42 kD), recombinant human          
interleukin-1 (IL-1 ), DMNQ, or menadione. Fnf and IL-1 elicited increased levels of NO inβ  β       β        
the media while DMNQ and menadione did not. DMNQ and menadione elicited increased             
hydrogen peroxide (H​2​O​2​) levels in media but Fnf and IL-1 did not. Pre-treatment with the          β      
antioxidant MnTBAP reduced Fnf and IL-1 -associated NO production and decreased MMP-13     β       
production. These results suggest that NO and/or peroxynitrite may play a role in contributing to               
the production of degradative factors such as MMP-13​. Chondrocytes were also treated with             
H​2​O​2 in a dose curve [0.5 to 50 μM] or Fnf, a physiological source of ​H​2​O​2​. Phosphorylation of                  
MAPKs (JNK, ERK, p38) was measured in cell lysates using phospho-antibodies and oxidation             
was measured by probing BIAM pulled-down proteins with antibodies to MAPKs. Low levels of              
ROS were required for JNK activation and both low and high levels activated p38. ERK was less                 
sensitive to oxidation than JNK but was more sensitive than p38. This suggests that differential               
activation of MAPKs by ROS levels represents an additional layer of regulation that             
distinguishes stress and non-stress signaling.  
 
Introduction 
 
Osteoarthritis (OA) is a debilitating, chronic disease. It is the most common form of arthritis               
globally (1). Due to rising obesity rates, a large aging population, and increased sports-related              
injuries, all of which contribute to OA pathogenesis, OA represents a sizable economic burden              
on afflicted patients. OA is marked by degradation of articular cartilage and ligaments, formation              
of osteophytes, and varying levels of inflammation within the synovium (1). These symptoms             
cause physical limitations that restrict daily functioning and decrease quality of life. There is              
currently no cure for OA, and the cost of care is high for the procedures and medications that                  
alleviate symptoms. Moreover, OA patients are often dissatisfied with current treatment options            
(2). Thus, it is necessary to expand fundamental knowledge of OA development and             
progression so that new therapeutics and pain management procedures can be developed.  
 
Osteoarthritis is a complex disease which is characterized by the degradation of articular              
cartilage due to the loss of matrix proteins (10). An accumulation of reactive oxygen species               
(ROS) plays a role in the degradation of cartilage (11). ​ROS are produced by cells to regulate                 
molecular pathways that mediate the response to a variety of signals. An imbalance between              
the production of ROS and the antioxidant capacity of the cell leads to oxidative stress, which                
disrupts physiologic signaling and is implicated in the pathogenesis of OA (5).  
 
Articular chondrocytes in OA joints are activated by inflammatory mediators that promote            
cartilage matrix destruction through stimulation of matrix metalloproteinase (MMP) production          
that includes MMP-13 (12). Nitric oxide (NO), a ROS, is produced by chondrocytes and is               
hypothesized to promote signals that result in increased MMP production. NO has been shown              
to readily interact with superoxide to create a more potent nitrosative oxidant, peroxynitrite, that              
is a potential mediator of cartilage damage (13). ​Manganese (III) tetrakis (4-benzoic            
acid)porphyrin chloride (​MnTBAP) is an antioxidant that acts as a peroxynitrite scavenger and             
superoxide dismutase mimetic. In this study, nitric oxide and hydrogen peroxide produced by             
several different stimuli (an inflammatory cytokine, interleukin-1 a matrix protein fragment,      ,β      
fibronectin fragment, and redox cycling quinones, DMNQ and menadione) were measured.  
Additionally, the pathological changes associated with OA can be induced by activation of MAP              
kinase (MAPK) cascades. These cell signaling pathways, which are regulated by reactive            
oxygen species or catabolic stimuli, cause downstream activation of transcription factors that            
regulate gene expression associated with degradative and inflammatory activity.  
The overall goal of this study was to assess the relationship between catabolic stimuli and ROS                
levels as well as how ROS influences MAP kinase signaling and  MMP-13 production.  
 
Methods 
Antibodies and Reagents- Antibodies used included phospho-JNK, total JNK2, phospho-c-Jun,          
total c-Jun, phospho ERK, total ERK, phospho Elk-1, total Elk-1, phospho-p38, total p38,             
phospho-MAPKAPK2/MK2, total MAPKAPK2/MK2, which were purchased from Cell Signaling         
Technologies. Total MMP-13 antibody was purchased from EMD Millipore and total MMP-2            
antibody was purchased from Calbiochem. H​2​O​2 was used as the ROS (Sigma-Aldrich).            
DCP-Bio1 labeling reagent was generously provided by the Poole lab at Wake Forest University              
(Winston-Salem, NC). Biotinylated iodoacetamide was purchased from Life Technologies         
Corporation. Endotoxin-free recombinant fibronectin fragment was produced as described (9)          
and used as a physiologic stimulus generating low levels of H​2​O​2​. ​Recombinant human IL-1             β  
protein (R&D Systems), DMNQ (Sigma), and menadione (Sigma) were also used to stimulate             
ROS production. Manganese (III) tetrakis (4-benzoic acid)porphyrin chloride (​MnTBAP) was          
purchased from Santa Cruz Biotechnology. 
 
Chondrocyte Isolation and Culture- ​Human articular cartilage was collected from taluses of            
donor tissue acquired through the Gift of Hope Organ and Tissue Donor Network and Rush               
University Medical Center (Chicago, IL). Donor cartilage was examined for degeneration using            
Collins’ 5-point scale and only samples of grade 1 were utilized for this study. Chondrocytes               
were isolated and cultured as described (7). 
 
Quantification of Extracellular ROS Production in Media​- Primary chondrocytes were cultured in            
monolayer containing 10% fetal bovine serum DMEM-F12 with antibiotics was changed to            
serum-free, phenol-red free DMEM-F12 with antibiotics and cultured overnight prior to           
stimulation with Fnf (1 ) and IL-1 (10ng/mL) for either 6hr or 24 hr incubation. Cells were   Mμ   β           
also treated with DMNQ (25 ) and menadione (25 ) but for 1hr only due to cell death with    Mμ    Mμ           
longer incubation periods. A Griess Reagent assay was performed using ​Griess Reagent            
(N-(1-naphthyl)ethylenediamine dihydrochloride and sulfanilic acid) to determine nitrite        
concentration as a means of indirectly measuring nitric oxide concentration as it spontaneously             
oxidizes to become nitrite (8). Experimental media samples were combined with Griess Reagent             
and incubated at room temperature for 30 minutes after which absorbance was read by              
SpectraMax M2 at 548nm. Absorbance values were calibrated to concentrations using a            
standard curve with sodium nitrite solutions (1-100uM). A Fluorimetric Hydrogen Peroxide Assay            
Kit (Millipore Sigma) was used to quantify ​H​2​O​2 levels in the conditioned media through              
utilization of a peroxidase substrate to generate a red fluorescence, which was read by              
SpectraMax M2 at ex​=540nm/ em​=590nm. ​H​2​O​2 concentration for the experimental samples   λ λ        
was determined from a standard curve (0-10 uM).  
 
Pre-Treatment With MnTBAP Prior to Application of Stimulus​- Cells in ​DMEM-F12 media            
containing FBS and antibiotics were changed to serum-free, phenol-red free DMEM-F12 with            
antibiotics and cultured overnight. For the antioxidant experiment, cells were pretreated with            
MnTBAP for 30 minutes prior to stimulation, and then stimulated with either Fnf (1 ) or IL-1             Mμ   β
(10 ng/mL) for 24 hours. Conditioned media was collected and mixed with 4X Laemmli Sample               
buffer containing beta-mercaptoethanol, boiled for 5 minutes and then centrifuged.          
Immunoblotting, as described in the Immunoblotting section, was then performed to determine            
MMP-13 production. Blots were imaged using Azure c600. Loading controls were determined            
via stripping and reprobing the membranes with antibodies to total protein. 
 
ROS Treatment, Cell Lysis, and Protein Quantification- ​Cells were cultured in serum free media              
overnight prior to stimulation. Cultures from each donor were treated for 30 minutes with a               
hydrogen peroxide dose curve including concentrations of 0.5, 1.0, 3.0, 10.0, and 50.0 μM.              
Afterwards, the cells were rinsed twice with Dulbecco’s phosphate-buffer saline (DPBS) to            
remove the peroxide treatments. For cell signaling experiments, cells were lysed in standard             
lysis buffer including phenylmethanesulfonyl fluoride (PMSF; Sigma-Aldrich) and phosphatase         
inhibitor cocktail 2 (Sigma-Aldrich). For biotinylated iodoacetamide (BIAM) experiments, cells          
were lysed with lysis buffer (lysis buffer, PIC, PMSF) containing NEM (10 mM). The samples               
were then rotated for 30 minutes at 4°C. The samples were desalted over Zebra columns, which                
were previously centrifuged twice at 1000g for 2 minutes. The desalted samples were             
transferred to eppendorf tubes and treated with DTT (5mM) for an hour at 4°C. The samples                
were then labeled with BIAM for an hour while rotating at 4°C. The samples were centrifuged for                 
10 minutes and BCA analysis was performed on the supernatant. Streptavidin beads and             
samples were added to columns and rotated overnight at 4°C. The columns were washed three               
times with PBS for five minutes and centrifuged at 400g for 30 seconds after each wash. 2x                 
loading buffer (100 μL) was added to each column and boiled for 10 minutes. The samples were                 
centrifuged at 1000g for 4 minutes. 
 
Immunoblotting- ​Samples were electrophoresed through 10% SDS-PAGE for 90 minutes at 120            
V and transferred to nitrocellulose paper for 70 minutes at 120 V. Membranes were washed with                
tris buffered saline with tween (TBST) and incubated in 5% blocking buffer for an hour. Next,                
membranes were immunolabeled with respective primary antibodies overnight at 4°C. The           
following day, membranes were washed with TBST and incubated with an HRP-tagged            
secondary antibody for an hour before viewing using enhanced chemiluminescence (ECL).           
Loading controls were determined via stripping and reprobing the membranes with antibodies to             
total protein. Densitometric quantification was done using ImageJ software. 
 
Statistical Analysis- The data was analyzed using GraphPad Prism version 7 (Graphpad            
Software, Inc.). Significant differences were determined using a one-way ANOVA test with a             
level of p < 0.05 considered significant.  
 
 
Results 
Extracellular NO and H​2​O​2 Production After Stimulus With Fnf, IL-1 , DMNQ, or         β    
Menadione 
To determine the effect of catabolic stimuli on cells, extracellular NO was quantified using a               
Griess Assay measuring nitrite, which is the product of nitric oxide becoming auto-oxidized to              
form dinitrogen trioxide and then decomposed (8). Extracellular ​H​2​O​2 was quantified using an             
assay that directly measured ​H​2​O​2​. ​Nitrite concentration was significantly higher in media            
treated with either Fnf or ​IL-1 after a period of 24 hrs as compared to the control (P<0.0001).     β             
Nitrite concentrations in the control media and media treated for 6 hrs were similar (Fig. 1A).                
Nitrite concentrations after stimulus with DMNQ and menadione were low and did not differ from               
control nitrite levels indicating that nitrite was not produced by either reagent after 1hr incubation               
(Fig.1C). There were no significant differences in media levels of H​2​O​2 in cells treated with Fnf                
or IL-1 (Fig.1B). However, extracellular H​2​O​2 levels were higher in media treated with DMNQ β             
and two-fold higher with menadione, as compared to the control (Fig.1D). Overall, these results              
suggest that Fnf and ​IL-1 cause the cell to produce and release high amounts of nitric oxide     β             
while DMNQ and menadione cause the cell to produce and release high amounts of H​2​O​2​. 
 
  
Figure 1. Extracellular ROS Production After Stimulus With Fnf, IL-1 , DMNQ, or Menadione. ​(A) Confluent chondrocytes in          β         
serum-free, phenol-free media were treated with Fnf or IL-1 for a duration of 6 or 24 hrs. Controls were treated with either PBS or         β                
additional media. Nitrite concentration was calculated using the Griess Reagent Assay. **** indicates a significance of p<0.0001.                 
(n=6) (B) Confluent chondrocytes in serum-free, phenol-free media were treated with Fnf or IL-1 for a duration of 6 or 24 hrs.              β         
Controls were treated with either PBS or additional media. H​2​O​2 concentration was determined using the Hydrogen Peroxide Assay.                  
There was not a significant difference in H​2​O​2 concentrations for different durations of stimulus. (n=5) (C) Confluent chondrocytes in                   
serum-free, phenol-free media were treated with DMNQ or menadione for 1 hr or pre-treated with MnTBAP for 30 minutes before                    
DMNQ or menadione treatment. Controls were treated with DMSO. Nitrite concentration was quantified using the Griess Reaction                 
Assay (n=3). (D) Cells were treated as indicated in part C. H​2​O​2 concentration was quantified. (n=3). * indicates a significance of                     
p<0.0430.  *** indicates a significance of p<0.0007. 
 
 Antioxidant Pretreatment Decreases Production of MMP-13 in response to Fnf and ​IL-1 β  
Treatment with either Fnf or ​IL-1 resulted in high levels of MMP-13 in conditioned media     β           
relative to the control. Pre-treatment with MnTBAP decreased production of MMP-13 in            
response to Fnf and IL-1 MMP-2 appeared as a lower band in cells treated with MnTBAP    .β             
(Fig. 2) indicating that there may have been cleavage of the enzyme to pro-form.  
 
Figure 2.  ​Decrease in MMP-13 Production With Antioxidant Pre-Treatment Prior to Stimulus With Fnf and IL-1 .  (A) ​Confluent β  
chondrocytes were serum-starved overnight and treated with Fnf or IL-1  for 24 hours or pre-treated with MnTBAP(250  forβ M )μ  
30min prior to 24hr Fnf or IL-1 treatment. Media treated with PBS or additional media served as controls.  Equal amounts of media β  
were collected and mixed with 4x Laemmli Buffer, boiled for 5min, and ran on a a 10% reducing gel. Lanes were probed with a total 
MMP-13 antibody and imaged using the Azure Imager. Lanes were then probed with a total MMP-2 antibody as a loading control 
and imaged.  (B) ​Densitometric analysis from immunoblot for total MMP-13 (n=3). 
To observe the effect of the antioxidant on ROS production, ROS levels in cells treated with                
MnTBAP were quantified. High levels of NO and lower levels of H​2​O​2 were measured in cells                
treated with Fnf and IL-1 as compared to the control (Fig.1). Nitrite levels were significantly    β           
decreased following treatment with MnTBAP (p<0.0001) (Fig. 3A). H​2​O​2 levels were also            
decreased in response to pretreatment with MnTBAP followed by treatment with all four             
stimuli:Fnf, IL-1 DMNQ, and menadione (Fig.1D,3B).,β  
 
 
 
Figure 3. Extracellular ROS Production ​With Antioxidant Pre-Treatment Prior to Stimulus with Fnf or IL-1 . ​(A) Confluent               β    
chondrocytes in serum-free, phenol-free media were treated with Fnf for 24 hours or pre-treated with MnTBAP for 30min prior to                    
F-nf treatment for 24 hours. Media with PBS served as a control. Cells were also treated with IL-1 for a duration of 24hrs or                  β       
pretreated with MnTBAP for 30min and then treated with IL-1 for 24 hrs. Media with additional media served as a control. Nitrite          β             
concentration was calculated using the Griess Reagent Assay. **** indicates a significance of p<0.0001. (n=6) (B) Media with the                   
same stimuli listed in part A. H​2​O​2 concentration was calculated using the Hydrogen Peroxide Assay. ** indicates a significance of                    
p<0.0037.  *** indicates a significance of p<0.0007.  (n=5) 
JNK More Susceptible to Oxidation ​ ​than Other MAPKs in Response to ROS 
Primary human chondrocytes were treated with Fnf or H​2​O​2​ on a dose curve with concentrations 
of 0.5, 1.0, 3.0, 10.0, and 50.0 μM  to stimulate oxidative stress. Phosphorylation of JNK in 
response to H​2​O​2​ was detected using the phospho-JNK antibody. Phosphorylation of JNK was 
observed at low concentrations of H​2​O​2​ beginning at 0.5 μM (Fig. 4A). The highest level of 
phosphorylation was observed at H​2​O​2​ concentration of 1.0 μM (Fig. 4B). JNK2 thiol oxidation 
was measured using BIAM labeling. BIAM labels Cys-S-S-Cys, Cys-GSH, Cys-SN and other 
oxidized species. JNK2 oxidation was detected at a low H​2​O​2​ concentration of 0.5 μM up to the 
highest H​2​O​2​ concentration of 50 μM  (Fig.4C). To analyze how JNK activity was altered by the 
observed phosphorylation and oxidation at different H​2​O​2​ levels, a downstream target of JNK2 
used as a marker of JNK2 activity, c-Jun, was investigated. c-Jun demonstrated similar 
experimental trends in that the highest level of phosphorylation was observed when cells were 
treated with 1.0 μM dose of H​2​O​2​  (Fig.4D,E). Moreover, c-Jun was not pulled down in BIAM 
labeling experiments for any of the donors tested (data not shown), suggesting that perhaps 
c-Jun is more resistant to oxidation than its upstream activator JNK2 and that regulation occurs 
directly at JNK rather than at c-Jun in the signaling stream. 
 
Figure 4.  ​Effects of Increasing H​2​O​2​ Concentration on JNK/c-Jun Phosphorylation and Oxidation​. (A) Confluent human 
chondrocytes were treated with ​H​2​O​2​ concentrations 0.5-50 μM, and lysed samples were loaded onto 10% reducing gels. 
Membranes were probed with phospho JNK antibody or  c-Jun antibody. (B) Densitometric analysis from immunoblot for JNK 
phosphorylation and c-Jun phosphorylation. (n=7)  (C) Confluent human chondrocytes were treated with ​H​2​O​2​ concentrations 0.5-50 
μM, BIAM labeling and pulldown were performed, and samples were loaded onto 10% reducing gels. Membranes were probed with 
total JNK2 antibody. (n=3) 
 
 
 
 
ERK Pathway Exhibits Intermediate Sensitivity to ROS 
Levels of phosphorylated ERK in response to ROS were measured using phospho-ERK            
antibody. ERK showed the highest level of phosphorylation under H​2​O​2 concentration of 1.0 μM              
(Fig.5A), which was the same concentration resulting in the highest level of phosphorylation for              
JNK2 (Fig.4B and 5B). Phosphorylation levels seemed to decrease slightly with increasing            
doses of H​2​O​2 (Fig.5B). Oxidation was measured using previously mentioned techniques and            
high amounts were observed at H​2​O​2 concentrations of 10μM and 50μM (Fig.5C). ERK also acts               
as a kinase for the phosphorylation of Elk-1. However, due to issues with antibody specificity,               
Elk-1 data was inconclusive in determining activation and response to H​2​O​2​ treatment. 
 
Figure 5. ​Effects of H​2​O​2 on ERK Phosphorylation and Oxidation. ​(A) Samples treated with H​2​O​2 concentrations 0.5-50 μM were                   
loaded onto 10% gels and ran under reducing conditions. Membranes were probed with phospho ERK antibody. (B) Densitometric                  
analysis immunoblot for ERK phosphorylation. (n=7) (C) Confluent human chondrocytes were treated with H​2​O​2 concentrations               
0.5-50 μM and lysed samples ran on 10% gels under reducing conditions. Membranes were probed with total ERK antibody. (n=1) 
 
 
 
 
 
P38 Demonstrates Least Susceptibility to Oxidation in Response to ROS          
Treatment 
Phosphorylation of p38 was observed up to 50 μM of H​2​O​2 using phospho p38 antibody (Fig                
6A). This was tested by examining the phosphorylation status of the downstream target of p38,               
MK2. MK2 did show phosphorylation up to the highest concentration of H​2​O​2 tested, but              
concentrations of 10 and 50 μM were comparable to control suggesting some p38 inhibition.              
p38 was detected as oxidized at concentrations where phosphorylation was also measurable            
(Fig. 6). However, oxidation at H​2​O​2 concentrations 10 and 50μM was notably higher and this               
was also reflected in MK2 oxidation. Taken together this data suggests there are more oxidized               
species of p38 than phosphorylated at concentrations of ≥10 μM and that p38 is inactive at                
those concentrations despite showing sustained phosphorylation.  
 
Figure 6.​Effects of ​H​2​O​2 on p38/MK2 Phospho​rylation and Oxidation. (A) Confluent human chondrocytes were treated with                 
H​2​O​2 concentrations 0.5-50 μM and lysed samples ran on 10% gels under reducing conditions. Membranes were probed with                  
phospho p38 antibody. (B) Densitometric analysis from immunoblot for p38 phosphorylation (C) Confluent human chondrocytes               
were treated with ​H​2​O​2 concentrations 0.5-50 μM and lysed samples loaded onto 10% gels; the gels were ran under reducing                    
conditions. Membranes were probed with total p38 antibody. (D) Confluent human chondrocytes were treated with ​H​2​O​2                
concentrations 0.5-50 μM and lysed samples were loaded onto 10% gels; the gels were ran under reducing conditions. Membranes                   
were probed with phospho MK2 antibody. (E) Densitometric analysis from immunoblot for MK2 phosphorylation (F) Cells were                 
treated with ​H​2​O​2 concentrations 0.5-50 μM, BIAM labeling and pulldown were performed, and samples were ran on 10% reducing                   
gels. Membranes were probed with total MK2 antibody. (n=5) 
 
Discussion 
The purpose of this study was to investigate how ROS regulate cellular mechanisms of              
inflammation and cartilage degradation in OA​. Four different catabolic stimuli: Fnf, IL-1 ,           β  
DMNQ, and menadione showed varying effects on the production and release of ROS. Cells              
treated with Fnf and IL-1 demonstrated a significant release of NO while cells treated with    β           
DMNQ and menadione demonstrated a significant release of H​2​O​2​. Pretreatment of cells with             
MnTBAP, a peroxynitrite scavenger and superoxide dismutase mimetic, prior to stimulus with            
Fnf and IL-1 decreased expression of MMP-13, an enzyme implicated in cartilage  β           
degradation. Pretreatment with MnTBAP reduced extracellular levels of NO and H​2​O​2 following            
treatment with all four catabolic stimuli. Additionally, oxidative stress in OA is known to              
differentially activate various MAP kinase cascades causing an imbalance between catabolic           
and anabolic signaling. ​Low levels of ROS were required for JNK activation and both low and                
high levels activated p38. ERK was less sensitive to oxidation than JNK but was more sensitive                
than p38. These results suggest that MAPKs are differently activated by varying ROS levels.  
Chondrocytes produce the secondary messenger nitric oxide (NO) which often readily interacts            
with superoxide to form peroxynitrite, a harmful ROS that can mediate cartilage damage by              
promoting signals that increase matrix metalloproteinase (MMP) production (14,15). We          
hypothesized that ​MnTBAP, a peroxynitrite scavenger and superoxide dismutase mimetic,          
would rescue and rebalance the redox state of cultured chondrocytes treated with oxidative             
stress-inducing reagents through inhibition of the MMP-13 production. 
Several studies have shown that intracellular ROS increases in response to stimulus with             
cytokines, ​redox cycling quinones, and matrix protein fragments (5,16,18). However, there have            
been few studies that looked at production of extracellular ROS with these stimuli. This study               
showed that Fnf and ​IL-1 caused an increase in nitric oxide release after 24hr incubation but    β            
6hr incubation displayed similar levels to control. This suggests that nitric oxide is not produced               
in significant amounts immediately following stimulus. Treatment with DMNQ and menadione           
showed no change in nitric oxide levels, meaning that they also do not cause immediate nitric                
oxide production. This may be due to short incubation time (1hr). However, this can not be                
determined due to cellular death after incubations of longer than 1hr with DMNQ and              
menadione, which could be due to the production of other ROS that initiate cell death (16).  
Extracellular H​2​O​2 levels did not significantly change following treatment of cells with Fnf or              
IL-1 ​relative to the control. However, treatment with DMNQ and menadione significantlyβ             
increased H​2​O​2 levels relative to controls. This suggests that DMNQ and menadione lead to              
significant H​2​O​2 production intracellularly, which is then released or diffuses out of the cell. The               
difference in incubation between Fnf and ​IL-1 (6hr or 24hr) and DMNQ and menadione (1hr)      β         
could account for this difference, since H​2​O​2 is a transient species rapidly turned over. Overall,               
this data indicates that nitric oxide is significantly produced after a long period of signaling               
whereas H​2​O​2​ is produced more immediately.  
Additionally, cells treated with Fnf and ​IL-1 were pre-treated with MnTBAP, a peroxynitrite      β       
scavenger and superoxide dismutase mimetic, to observe the role NO and H​2​O​2 production             
plays in influencing MMP-13 production and resultant degradation of the cellular matrix. It has              
been shown that increased production of several ROS but not NO are obligatory secondary              
messengers in the Fnf signaling pathway leading to increased production of MMP-13 production             
(19). This study sought to provide confirmation of these results and additionally observe the              
effects of an additional stimulus, IL-1 . Treatment with either Fnf or ​IL-1 alone ​showed high     β       β    
levels of NO as well as increases in MMP-13 production, but pre-treatment with MnTBAP              
significantly reduced the production of MMP-13. ​However, further experiments will need to be             
done utilizing an iNOS inhibitor to determine the effect of NO as a secondary messenger               
following IL-1 stimulus. Further experiments will also examine the effect MnTBAP β           
pretreatment in samples treated with DMNQ and menadione has on MMP-13 production.            
MMP-13 is increased in OA cartilage and is thought to play a key role in the degradation of                  
collagen (17). Thus, targeting signaling pathways which regulate MMP-13 production could           
present a potential therapeutic approach for slowing cartilage degradation in osteoarthritis.  
Furthermore, MAP kinases signaling cascades are key regulators of transcriptional factor           
activation. These transcriptional factors control expression of a number of genes implicated in             
inflammation, cell proliferation, and production of matrix-degrading enzymes which are all           
characteristics of osteoarthritis (2). MAP kinases are differentially regulated by ROS, and if ROS              
accumulate to high levels, the cell enters a state of oxidative stress where aberrant MAP kinase                
signaling can occur and drive pathogenesis (1). For example, oxidative stress in the context of               
OA is known to differentially activate various MAP kinase cascades, causing increases in             
catabolic signaling and inhibition of anabolic signaling. This overall shift causes imbalance that             
leads to cell matrix inflammation and degradation.  
MAP kinases investigated in this study were JNK2, ERK, and p38 along with the downstream               
targets they phosphorylate: c-Jun, Elk-1, and MK2 respectively. This study demonstrated that            
JNK2 is the most susceptible to oxidation by ROS in comparison to ERK and p38. The                
downstream target of JNK2, c-Jun, showed sustained phosphorylation past the point of            
inhibition for ​JNK. That suggests there are either other upstream JNK isoforms or MAP kinases               
that can phosphorylate c-Jun, or there is a lag time between the inhibition of JNK and the                 
successive disappearance of phosphorylation of c-Jun. JNK2 is widely expressed in joint tissues             
and when activated, increases cytokine and MMP production, which play a role in cellular matrix               
remodeling by functioning to degrade the cellular matrix (2,4). Thus, ROS-based inactivation of             
JNK signaling could be a positive thing in the context of OA because the typical increases in                 
cytokine and MMP production would be stopped. 
ERK was shown to be less susceptible to oxidation than JNK2 but more susceptible than p38.                
Data for phosphorylation of its downstream substrate, Elk-1, was inconclusive, thus, no            
conclusions regarding ERK activity being affected by oxidation could be definitively made. Elk-1             
has regulatory activity of growth signaling pathways that manage cell proliferation and tissue             
homeostasis (2). ERK and Elk-1 also are involved in the transcriptional regulation of MMP-13              
production (2). Thus, this particular pathway should be further investigated in the future to              
determine how its role is delineated in chondrocytes and OA tissue from that of other MAP                
kinases. 
P38 phosphorylation was sustained throughout all concentrations of H​2​O​2​, as was its            
downstream target, MK2. At peroxide concentrations ≥10 μM, phosphorylation of p38 and MK2             
were slightly decreased but still present. The oxidation data reflected this trend also with the               
most labeling occurring with treatment of H​2​O​2 concentrations ≥10 μM. This indicates that p38              
was the least susceptible to oxidation out of all the MAP kinases, and it is only after a certain                   
degree of oxidation that activity is impacted. P38 is expressed in most tissues, albeit not in all of                  
its isoforms, and is mainly activated through inflammatory- and stress-induced stimuli (2). p38             
has been previously reported to be more resistant to oxidation and subsequent inhibition of              
function than other kinases (3). Notably in this study, despite oxidation, at no concentrations              
tested was p38 activity completely abolished. The signaling pathway of p38 acts as a pro-death               
cascade in degradation of diseased chondrocytes. P38, like ERK, is also associated with             
inhibition of aggrecan expression (2). Thus, altogether, the resistance observed of p38 signaling             
to oxidation-based inhibition could be a contributing pathogenic factor in OA progression. 
Overall, this data suggests that catabolic stimuli affect ROS production differently and implicates             
ROS as a secondary messenger in the production of MMP-13. ROS-level specificity also             
represents an additional, previously unappreciated layer of regulation for MAP kinase activation.            
This model proposes that the differential response based on ROS levels is a way for the cell to                  
adjust appropriately and try to restore or maintain homeostasis. This study offers further support              
that catabolic stimuli, which are increased in OA tissue, increases ROS and ROS-based             
responses. It is not clear from this work if the ROS generated by catabolic stimuli would be                 
directly activating or inhibiting MAP kinase signaling pathways. However, the oxidative inhibition            
of MAP kinases perhaps represents a potential means in repairing osteoarthritis-associated           
dysfunction of these pathways. 
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